Baruch Halpert
Presidente en Terragenic International Ltd. .
Perfil
Baruch Halpert is currently the Executive Chairman at Terragenic International Ltd.
He previously worked as a Director at Enlivex Therapeutics Ltd.
and holds a graduate degree from The University of Reading.
Cargos activos de Baruch Halpert
| Empresas | Cargo | Inicio |
|---|---|---|
| Terragenic International Ltd. | Presidente | 01/01/2018 |
Antiguos cargos conocidos de Baruch Halpert.
| Empresas | Cargo | Fin |
|---|---|---|
| ENLIVEX THERAPEUTICS LTD. | Director/Miembro de la Junta | - |
Enlivex Therapeutics Ltd. /Old/
 Enlivex Therapeutics Ltd. /Old/ Medical SpecialtiesHealth Technology Enlivex Therapeutics Ltd. develops autologous and allogeneic drug pipeline for treatment of autoimmune and inflammatory conditions. It produces treatment devices for CAR-T cancer treatment procedures, Graft-versus-Host disease resulting from bone-marrow transplantations, solid organ transplantations and an assembly of autoimmune and inflammatory conditions, such as Crohn’s disease, rheumatoid arthritis, gout, multiple sclerosis and other disorders. The company was founded by Dror Mevorach in 2005 and is headquartered in Jerusalem, Israel. | Director/Miembro de la Junta | - |
Formación de Baruch Halpert.
| The University of Reading | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| ENLIVEX THERAPEUTICS LTD. | Health Technology |
| Empresas privadas | 2 |
|---|---|
Enlivex Therapeutics Ltd. /Old/
Enlivex Therapeutics Ltd. /Old/ Medical SpecialtiesHealth Technology Enlivex Therapeutics Ltd. develops autologous and allogeneic drug pipeline for treatment of autoimmune and inflammatory conditions. It produces treatment devices for CAR-T cancer treatment procedures, Graft-versus-Host disease resulting from bone-marrow transplantations, solid organ transplantations and an assembly of autoimmune and inflammatory conditions, such as Crohn’s disease, rheumatoid arthritis, gout, multiple sclerosis and other disorders. The company was founded by Dror Mevorach in 2005 and is headquartered in Jerusalem, Israel. | Health Technology |
| Terragenic International Ltd. |
- Bolsa de valores
- Insiders
- Baruch Halpert